In the News
powered by Ovast-
Generics Drive Down Drug Prices In India, TPP Trying To Stop That
techdirt.com 4 days, 15 hours agoBack in March, we wrote about an important development in India, where a compulsory license for Bayer's Nexavar anti-cancer drug was granted. Bayer, of course, is fighting back : in its 37-page appeal to the Intellectual Property Appellate Board, Bayer has "demanded the withdrawal of the country’s first compulsory license given to Natco Pharma, arguing that a three-fourths reduction in the price of the anti-cancer drug by another Indian firm has made the permit redundant and its patent itself is vulnerable
-
Bee Health Achieve BRC Level 6 Global Food Audit Status
pr.com 1 week, 6 days agoBee Health today announced they have achieved the highest quality standard for Food Supplement production with Level 6 Global Food BRC approval. [PR.com]


Loading More Stories